Maron, Bradley A.
Altucci, Lucia
Balligand, Jean-Luc
Baumbach, Jan http://orcid.org/0000-0002-0282-0462
Ferdinandy, Peter
Filetti, Sebastiano
Parini, Paolo
Petrillo, Enrico http://orcid.org/0000-0002-9119-5434
Silverman, Edwin K.
Barabási, Albert-László
Loscalzo, Joseph http://orcid.org/0000-0002-1153-8047
Maron, Bradley A.
Altucci, Lucia
Balligand, Jean-Luc
Baumbach, Jan http://orcid.org/0000-0002-0282-0462
Ferdinandy, Peter
Filetti, Sebastiano
Parini, Paolo
Petrillo, Enrico http://orcid.org/0000-0002-9119-5434
Silverman, Edwin K.
Barabási, Albert-László
Loscalzo, Joseph
,
Article History
Received: 14 February 2020
Accepted: 6 July 2020
First Online: 31 August 2020
Competing interests
: B.A.M.: Consultant for Actelion Pharmaceuticals for a project unrelated to this current work; co-inventor on U.S. patent pending PCT/US2019/059890 and U.S. patent 9,605,047, which are not related to the current work. P.F.: Founder and CEO of Pharmahungary Group, a group of R&D companies. E.S.: In the past 3 years, he has received institutional grant support from GSK and Bayer. A.L.B.: is the founder of Scipher, Foodome and Nomix, companies that are using tools of network science to make an impact on health. J.L.: Co-founder of Scipher (for profit) Scientific Advisory Board (2013-to present), and consulting services. The remaining authors declare no competing interests.